Cervical cancer trials in China

In China 159 Also abroad 532

159 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
A Clinical Study on Alleviating Hemorrhoids-related Symptoms of Pelvic Radiation Therapy
Where
Shanghai
Age
19 years and over
People
300
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07175584
Phase 2/3Not yet taking people in China
Efficacy and Safety of LB1410 Plus Lenvatinib With or Without LB4330 in Advanced Recurrent/Metastatic Cervical Cancer
Where
Shanghai
Age
18 years and over
People
120
Run by
L & L Bio Co., Ltd., Ningbo, China
See details and how to joinNCT07177716
Early phase 1Taking people
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Where
Hefei
Age
19 years to 70 years
People
36
Run by
Anhui Provincial Hospital
See details and how to joinNCT07106814
Phase 2Not yet taking people in China
The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC
Where
Ji'an
Age
18 years to 75 years
People
33
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07172217
Phase 2Taking people
Neoadjuvant Iparomlimab and Tuvonralimab Plus Chemotherapy-eclipse for Locally Advanced Cervical Cancer (NICE-CC)
Where
Fuzhou
Age
18 years to 70 years
People
43
Run by
Fujian Cancer Hospital
See details and how to joinNCT07055399
No phaseTaking people
The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)
Where
Chongqing
Age
18 years to 70 years
People
452
Run by
Chongqing University Cancer Hospital
See details and how to joinNCT04555226
No phaseTaking people
A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB
Where
Guangzhou, Shenzhen
Age
18 years and over
People
200
Run by
Sun Yat-sen University
See details and how to joinNCT06781151
Phase 1Taking people
A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Where
Zhengzhou
Age
18 years to 75 years
People
21
Run by
GONGCHU Biotechnology Co., Ltd
See details and how to joinNCT06508307
Phase 2Taking people
Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer
Where
Shanghai
Age
18 years to 75 years
People
20
Run by
Obstetrics & Gynecology Hospital of Fudan University
See details and how to joinNCT07130240
Phase 2Taking people
Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Where
Zhengzhou
Age
18 years to 75 years
People
29
Run by
The First Affiliated Hospital of Zhengzhou University
See details and how to joinNCT07104149
Phase 2Taking people
Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer
Where
Tianjin
Age
18 years to 75 years
People
34
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07092696
No phaseNot yet taking people in China
Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines
Where
Hefei
Age
18 years to 65 years
People
50
Run by
Anhui Provincial Hospital
See details and how to joinNCT07077980
No phaseTaking people
A Cohort Study of Uterine Malignancies
Where
Hangzhou
Age
20 years to 75 years
People
6,200
Run by
Women's Hospital School Of Medicine Zhejiang University
See details and how to joinNCT05635123
Phase 1Taking people
A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
Where
Hefei
Age
18 years to 75 years
People
20
Run by
Anhui Provincial Hospital
See details and how to joinNCT06232083
Phase 2Taking people
Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial
Where
Guangzhou
Age
18 years to 80 years
People
34
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07003620
No phaseNot yet taking people in China
Patient Journey in Advanced Gynecologic Cancers
Where
Chongqing, Guangzhou, Hefei, Wuhan
Age
18 years and over
People
780
Run by
Tongji Hospital
See details and how to joinNCT07015593
Phase 1/2Taking people
SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer
Where
Beijing
Age
18 years to 75 years
People
100
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06859775
Phase 1Taking people
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Where
Hangzhou
Age
18 years and over
People
30
Run by
Weijia Fang, MD
See details and how to joinNCT05518253
Phase 2Taking people
A Single-Arm, Phase II Clinical Trail of Cadonilimab Combined With Chemoradiotherapy in Oligometastatic Stage IVB Cervical Cancer
Where
Zhengzhou
Age
18 years and over
People
30
Run by
Xiangbo Wan
See details and how to joinNCT06998394
Phase 3Taking people
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
Where
Beijing, Changsha, Hangzhou, Hefei, Wuhan
Age
18 years to 75 years
People
440
Run by
Lee's Pharmaceutical Limited
See details and how to joinNCT06459687
No phaseTaking people
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
Where
Wenzhou
Age
18 years to 65 years
People
40
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT06052033
Phase 1Taking people
A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors
Where
Guangzhou
Age
18 years to 75 years
People
122
Run by
HC Biopharma Inc.
See details and how to joinNCT06307925
Phase 2Taking people
Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Where
Jinan
Age
18 years to 75 years
People
36
Run by
Shandong Cancer Hospital and Institute
See details and how to joinNCT06942416
Phase 2Not yet taking people in China
Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC
Where
Shanghai
Age
18 years to 75 years
People
30
Run by
RenJi Hospital
See details and how to joinNCT06916117
No phaseTaking people
Neoadjuvant Therapy in Cervical Cancer
Where
Jinan
Age
18 years to 70 years
People
48
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT06558682